142 related articles for article (PubMed ID: 29084640)
1. Sensitivity of cutaneous chronic myelomonocytic leukaemia lesions to hypomethylating treatment.
Di Battista V; Matteucci C; Pulini S; Calabrese G; Quintini M; Moretti M; Ballanti S; Canino S; Di Bartolomeo P; Mecucci C
Eur J Dermatol; 2017 Oct; 27(5):540-542. PubMed ID: 29084640
[No Abstract] [Full Text] [Related]
2. A multi-centre phase 2 study of azacitidine in chronic myelomonocytic leukaemia.
Drummond MW; Pocock C; Boissinot M; Mills J; Brown J; Cauchy P; Cross NC; Hartley S; Kell J; Szubert A; Cockerill PN; Bowen DT
Leukemia; 2014 Jul; 28(7):1570-2. PubMed ID: 24569776
[No Abstract] [Full Text] [Related]
3. Dismal outcome of acute myeloid leukemia secondary to myelodysplastic syndrome and chronic myelomonocytic leukemia after azacitidine failure in a daily-life setting.
Niscola P; Tendas A; Cupelli L; Giovannini M; Piccioni D; Scaramucci L; Dentamaro T; Del Poeta G; de Fabritiis P
Acta Haematol; 2015; 133(1):64-6. PubMed ID: 25139255
[No Abstract] [Full Text] [Related]
4. Validation of response assessment according to international consortium for MDS/MPN criteria in chronic myelomonocytic leukemia treated with hypomethylating agents.
Duchmann M; Braun T; Micol JB; Platzbecker U; Park S; Pilorge S; Beyne-Rauzy O; Vey N; Sébert M; Gruson B; Dumas PY; Guieze R; Chretien ML; Laribi K; Chait Y; Legros L; Sahnes L; Hirsch P; Salanoubat C; Solary E; Fenaux P; Itzykson R
Blood Cancer J; 2017 May; 7(5):e562. PubMed ID: 28498370
[No Abstract] [Full Text] [Related]
5. Chronic myelomonocytic leukemia treatment with azacitidine: what have we learned so far?
Breccia M; Voso MT; Alimena G
Leuk Res; 2013 Feb; 37(2):204-5. PubMed ID: 23174191
[No Abstract] [Full Text] [Related]
6. Leukemia cutis in a patient with chronic myelomonocytic leukemia.
Claßen A; Kitz J; Perske C; Overbeck T; Bertsch HP; Schön MP; Lippert U
J Dtsch Dermatol Ges; 2018 Jan; 16(1):81-83. PubMed ID: 29288601
[No Abstract] [Full Text] [Related]
7. Advanced chronic myelomonocytic leukemia in elderly and frail patients managed by azacitidine in the field of clinical practice.
Niscola P; Tendas A; Abruzzese E; Caravita T; Cupelli L; Giovannini M; Scaramucci L; Siniscalchi A; Trawinska MM; de Fabritiis P
Ann Hematol; 2017 Sep; 96(9):1591-1593. PubMed ID: 28702776
[No Abstract] [Full Text] [Related]
8. Chronic myelomonocytic leukemia coexisting with monoclonal gammopathy: concomitant response to azacitidine of both disorders.
Niscola P; Siniscalchi A; Tendas A; Scaramucci L; Fratoni S; de Fabritiis P; Caravita T
Ann Hematol; 2015 Oct; 94(10):1753-4. PubMed ID: 26088814
[No Abstract] [Full Text] [Related]
9. Azacitidine followed by radiotherapy as effective treatment for chronic myelomonocytic leukemia with extramedullary localization.
Serrao A; Loglisci G; Salaroli A; Zacheo I; Alimena G; Breccia M
Leuk Lymphoma; 2013 Feb; 54(2):411-2. PubMed ID: 22694794
[No Abstract] [Full Text] [Related]
10. Acquired alpha thalassemia myelodyslastic/myeloproliferative syndrome (ATMDS): evolution on hypomethylating agent therapy.
Rose C; Fournier M; Nibourel O; Herbaux C; Charpentier A; Renneville A; Pissard S; Badens C; Preudhomme C
Leuk Res; 2011 Nov; 35(11):e203-5. PubMed ID: 21831427
[No Abstract] [Full Text] [Related]
11. A rare case of acquired haemophilia in a patient with chronic myelomonocytic leukaemia successfully treated with decitabine.
Shah D; Kumar R; Gaikazian S
Haemophilia; 2014 Jan; 20(1):e92-4. PubMed ID: 24261579
[No Abstract] [Full Text] [Related]
12. [Treatment of two chronic myelomonocytic leukemia patients with Decitabine].
Wang L; Wang HX; Zhao J
Zhonghua Xue Ye Xue Za Zhi; 2011 Jul; 32(7):497. PubMed ID: 22213878
[No Abstract] [Full Text] [Related]
13. Favorable evolution of lung interstitial disease in a patient with chronic myelomonocytic leukemia treated with azacitidine.
Hilmi M; Bally C; Burns R; Lorillon G; Bergeron A; Fenaux P; Ades L
Ann Hematol; 2018 Mar; 97(3):541-542. PubMed ID: 29170809
[No Abstract] [Full Text] [Related]
14. Safety and efficacy of azacitidine in Belgian patients with high-risk myelodysplastic syndromes, acute myeloid leukaemia, or chronic myelomonocytic leukaemia: results of a real-life, non-interventional post-marketing survey.
Beguin Y; Selleslag D; Meers S; Graux C; Bries G; Deeren D; Vrelust I; Ravoet C; Theunissen K; Voelter V; Potier H; Trullemans F; Noens L; Mineur P
Acta Clin Belg; 2015 Feb; 70(1):34-43. PubMed ID: 25444072
[TBL] [Abstract][Full Text] [Related]
15. [Effectiveness of azacitidine in chronic myelomonocytic leukemia harboring del(20q) - a case report].
Manabe M; Okita J; Takakuwa T; Harada N; Aoyama Y; Kumura T; Ohta T; Furukawa Y; Mugitani A
Gan To Kagaku Ryoho; 2014 Jun; 41(6):781-4. PubMed ID: 25129095
[TBL] [Abstract][Full Text] [Related]
16. NICE guidance on azacitidine for the treatment of myelodysplastic syndromes, chronic myelomonocytic leukaemia, and acute myeloid leukaemia.
Miller W; Holden J; George E; Stein K
Lancet Oncol; 2011 Apr; 12(4):326-7. PubMed ID: 21598446
[No Abstract] [Full Text] [Related]
17. Treatment of chronic myelomonocytic leukemia with 5-Azacitidine: a case series and literature review.
Thorpe M; Montalvão A; Pierdomenico F; Moita F; Almeida A
Leuk Res; 2012 Aug; 36(8):1071-3. PubMed ID: 22607959
[TBL] [Abstract][Full Text] [Related]
18. Micro-RNA-125a mediates the effects of hypomethylating agents in chronic myelomonocytic leukemia.
Berg JL; Perfler B; Hatzl S; Mayer MC; Wurm S; Uhl B; Reinisch A; Klymiuk I; Tierling S; Pregartner G; Bachmaier G; Berghold A; Geissler K; Pichler M; Hoefler G; Strobl H; Wölfler A; Sill H; Zebisch A
Clin Epigenetics; 2021 Jan; 13(1):1. PubMed ID: 33407852
[TBL] [Abstract][Full Text] [Related]
19. Activity of azacitidine in chronic myelomonocytic leukemia.
Costa R; Abdulhaq H; Haq B; Shadduck RK; Latsko J; Zenati M; Atem FD; Rossetti JM; Sahovic EA; Lister J
Cancer; 2011 Jun; 117(12):2690-6. PubMed ID: 21656746
[TBL] [Abstract][Full Text] [Related]
20. Optimizing treatments in rare diseases: will our evidence come from registry data?
Almeida AM
Leuk Res; 2014 Apr; 38(4):421-2. PubMed ID: 24631371
[No Abstract] [Full Text] [Related]
[Next] [New Search]
